HomeAPRE • NASDAQ
add
Aprea Therapeutics Inc
Previous close
$3.66
Day range
$3.34 - $3.55
Year range
$2.15 - $8.85
Market cap
19.27M USD
Avg Volume
32.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 354.62K | 11.00% |
Operating expense | 1.61M | -6.66% |
Net income | -3.78M | -18.08% |
Net profit margin | -1.07K | -6.37% |
Earnings per share | -0.64 | 25.58% |
EBITDA | -4.09M | -16.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.25M | 3.53% |
Total assets | 26.89M | 4.38% |
Total liabilities | 3.64M | -12.73% |
Total equity | 23.26M | — |
Shares outstanding | 5.43M | — |
Price to book | 0.90 | — |
Return on assets | -36.03% | — |
Return on capital | -40.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.78M | -18.08% |
Cash from operations | -2.47M | -10.10% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -1.16K | — |
Net change in cash | -2.44M | -4.87% |
Free cash flow | -1.23M | 7.08% |
About
Website
Employees
7
